D. Ulaeto

发表

Destabilization of α-Helical Structure in Solution Improves Bactericidal Activity of Antimicrobial Peptides: Opposite Effects on Bacterial and Viral Targets

K. Beck, M. Gumbleton, C. Morris, 2016, Antimicrobial Agents and Chemotherapy.

Assessment of antimicrobial peptide LL-37 as a post-exposure therapy to protect against respiratory tularemia in mice

H. Flick-Smith, M. Richards, S. Harding, 2013, Peptides.

, David Delivery Tissue Biocompatibility following Airway Antimicrobial Activity while Improving Lung Model Membrane Interactions , and Conformation , Maintains the Active Peptide Pegylation of Antimicrobial Peptides

K. Beck, C. Morris, D. Ulaeto, 2012 .

Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II

H. Atkins, J. Thwaite, T. Atkins, 2012, Peptides.

Pegylation of Antimicrobial Peptides Maintains the Active Peptide Conformation, Model Membrane Interactions, and Antimicrobial Activity while Improving Lung Tissue Biocompatibility following Airway Delivery

K. Beck, M. Gumbleton, C. Morris, 2012, Antimicrobial Agents and Chemotherapy.

A carpet-based mechanism for direct antimicrobial peptide activity against vaccinia virus membranes

H. Atkins, J. Thwaite, L. O’Brien, 2010, Peptides.

Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV

L. Zeitlin, Wei-Gang Hu, Pamela J. Glass, 2021, Viruses.

Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant

D. Pulford, A. Krieg, D. Ulaeto, 2017, Viruses.

The vaccinia virus 4c and A-type inclusion proteins are specific markers for the intracellular mature virus particle

D. Hruby, D. Grosenbach, D. Ulaeto, 1996, Journal of virology.

Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones

A. Rickinson, D. Ulaeto, A. Morgan, 1991, Journal of virology.

In vitro T cell responses to a candidate Epstein‐Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340

A. Rickinson, B. Morein, D. Ulaeto, 1988, European journal of immunology.

Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms

S. Weller, A. Phelps, K. Hamblin, 2021, bioRxiv.

A T-cell dormant state in the autoimmune process of nonobese diabetic mice treated with complete Freund's adjuvant.

E. Unanue, P. Lacy, D. Kipnis, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.

J. Robinson, D. Pulford, D. Ulaeto, 2004, Vaccine.

The cationic peptide magainin II is antimicrobial for Burkholderia cepacia-complex strains.

R. Titball, H. Atkins, J. Thwaite, 2009, Journal of medical microbiology.

Aerosol infection of Balb/c mice with eastern equine encephalitis virus; susceptibility and lethality

L. Zeitlin, A. Phelps, L. O’Brien, 2019, Virology Journal.

Susceptibility and Lethality of Western Equine Encephalitis Virus in Balb/c Mice When Infected by the Aerosol Route

L. Zeitlin, A. Phelps, L. O’Brien, 2017, Viruses.

Comparative efficacy of replicating smallpox vaccine strains in a murine challenge model.

A. Phelps, L. Eastaugh, D. Ulaeto, 2005, Vaccine.

Isolation of single-chain antibody fragments against Venezuelan equine encephalomyelitis virus from two different immune sources.

D. Ulaeto, D. Coates, J. Duggan, 2001, Viral immunology.

Development and operation of the defence COVID-19 lab as a SARS-CoV-2 diagnostic screening capability for UK military personnel

J. Miles, J. Thwaite, S. Weller, 2022, BMJ military health.

Semliki Forest virus and Sindbis virus, but not vaccinia virus, require glycolysis for optimal replication.

D. Ulaeto, James S Findlay, James S. Findlay, 2015, The Journal of general virology.

Comparative Efficacy of Intramuscular and Scarification Routes of Administration of Live Smallpox Vaccine in a Murine Challenge Model

A. Phelps, L. Eastaugh, D. Ulaeto, 2017, Vaccine.

Evolutionary implications of human transmission of monkeypox: the importance of sequencing multiple lesions

M. Carroll, J. Dunning, D. Ulaeto, 2022, The Lancet. Microbe.

Engineered Promoter-Switched Viruses Reveal the Role of Poxvirus Maturation Protein A26 as a Negative Regulator of Viral Spread

Paolo Ribeca, C. Maluquer de Motes, D. Ulaeto, 2021, Journal of virology.

Aerosol infection of Balb/c mice with eastern equine encephalitis virus; susceptibility and lethality

L. Zeitlin, A. Phelps, L. O’Brien, 2019, Virology Journal.

Amplification refractory mutation system PCR assays for the detection of variola and Orthopoxvirus

I. Damon, H. Meyer, G. Brightwell, 2004, Journal of Virological Methods.

Orthologs of the vaccinia A13L and A36R virion membrane protein genes display diversity in species of the genus Orthopoxvirus

H. Meyer, D. Pulford, D. Ulaeto, 2002, Archives of Virology.

Palmitylation of the Vaccinia Virus 37-kDa Major Envelope Antigen

D. Hruby, D. Grosenbach, D. Ulaeto, 1997, The Journal of Biological Chemistry.

Putative APOBEC3 deaminase editing in MPXV as evidence for sustained human transmission since at least 2016

M. Suchard, N. Loman, P. Lemey, 2023, bioRxiv.

Activity, Template Preference, and Compatibility of Components of RNA Replicase of Eastern Equine Encephalitis Virus

A. Merits, R. Skilton, D. Ulaeto, 2022, Journal of virology.

Cytokines and viral hemorrhagic fever: potential for therapeutic intervention

D. Ulaeto, R. D’Elia, R. D'Elia, 2015 .

Uses of vaccinia virus in vaccine delivery.

D. Hruby, D. Ulaeto, 1994, Current opinion in biotechnology.

Different Coexisting Mpox Lineages Were Continuously Circulating in Humans Prior to 2022

A. Rambaut, C. Ihekweazu, K. Lewandowski, 2023, bioRxiv.

Brefeldin A inhibits vaccinia virus envelopment but does not prevent normal processing and localization of the putative envelopment receptor P37.

D. Hruby, D. Grosenbach, D. Ulaeto, 1995, The Journal of general virology.

Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.

A. Phelps, L. Eastaugh, D. Ulaeto, 2007, Vaccine.

A prototype lateral flow assay for detection of orthopoxviruses.

P. Horby, M. Carroll, D. Ulaeto, 2022, The Lancet. Infectious diseases.

New nomenclature for mpox (monkeypox) and monkeypox virus clades

Rosamund F. Lewis, A. Rambaut, E. Lefkowitz, 2023, The Lancet. Infectious diseases.

Contact inactivation of orthopoxviruses by household disinfectants

D. Ulaeto, W. Butcher, 2005, Journal of applied microbiology.

Biocidal fusion peptides comprising LL-37 fragment

T. Atkins, D. Ulaeto, M. Fox, 2009 .